Importance/Background: During current public health emergency of COVID-19 pandemic,
repurposing of existing antiviral drugs may be an efficient strategy since there is no proven …

Background: The antiviral efficacy of remdesivir is still controversial. We aimed at evaluating
its clinical effectiveness in patients with COVID-19 requiring oxygen and/or ventilator …

Background We compared the efficacy of the antiviral agent, remdesivir, versus standard-of-
care treatment in adults with severe coronavirus disease 2019 (COVID-19) using data from a …

Background: Seeking new specific and effective drugs against Coronavirus Diseases-2019
(COVID-19) is of great importance. This study describes the efficacy of remdesivir with …

Background Real-world data on safety and clinical outcomes of remdesivir in COVID-19
management is scant. We present findings of data analysis conducted for assessing the …

We report the first successful treatment with the IL-1 receptor antagonist anakinra, in
association with the most promising and available antiviral therapy, of a severe case of …

Background: Remdesivir (Veklury®) and nirmatrelvir-ritonavir (Paxlovid®) are the two
commonly used antiviral agents for hospitalised patients suffering from Severe Acute …

Background There is an urgent need to understand the real-world effectiveness of
remdesivir in the treatment of SARS-CoV-2. Methods This was a retrospective comparative …

Introduction After emerging the global pandemic of SARS-CoV2 some preliminary studies
demonstrated the efficacy of antiviral treatments. But shortly thereafter, inconsistencies in the …

Several randomized controlled trials (RCTs) were conducted to investigate the effect of
remdesivir for patients with COVID-19, but their results were conflicting. Thus, we conducted …